Nestlé has completed its sale of 24.8% of Alcon’s issued and outstanding capital to Novartis following the conclusion of the regulatory process.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more


The cash transaction concerns 74 million Alcon shares at US$143 per share, with an aggregate value of $10.4bn after dividend adjustment.


The sale will have no capital gains tax impact on Nestlé which retains close to 52% of Alcon’s issued and outstanding capital and continues to fully consolidate Alcon.


The proceeds of the transaction will be used to reduce debt as Nestlé pursues its on-going share buy-back programme.


As announced on 7 April, Nestlé has a put option and Novartis a call option exercisable in the period from January 2010 to July 2011 on the remaining Alcon shares owned by Nestlé.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Just Food Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Just Food Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now